1st Quarter - Report
KING & SPALDING LLP for TAURX PHARMACEUTICALS LTD
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocacy related to Alzheimers treatments.
Foreign entity interest: TauRx Pharmaceuticals, LTD., Singapore, has an interest in the above reported issues. (100%)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DZIENGELSKI | Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst.(2013-2015),Leg. Asst. (2012-2013), Leg. Corr. (2011-2012),Staff Asst. (2010-2011);Energy and Commerce Committee:Staff (2015-2017) |
| DAVID JOSEPH FARBER | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAURX PHARMACEUTICALS LTD | Singapore | Singapore | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.